FDA Inspection 1279775 — Mary Bird Perkins Cancer Center
The FDA completed an inspection of Mary Bird Perkins Cancer Center on Aug 18, 2025 in Houma, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 18, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houma, LA (United States)